Transaction · 0000874015-25-000078

Monia Brett P

Monia Brett P, CEO, reported an open-market or private sale at IONIS PHARMACEUTICALS INC involving 13242.000000 shares for an estimated $429655.23. Reported holdings after the transaction were 219526.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCEO
IONSIONIS PHARMACEUTICALS INC
Filing timeFeb 04
Trade dateJan 31, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

IONS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
IONS since 2025-02-04Filed 576 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0000874015-25-000078
Common Stock
Transaction date
Jan 31, 2025
Filed Feb 04, 2025, 12:26 AM · 4d delay
Shares
13.2k sh
$3.24k per share
Estimated value
-$42.9M
Computed from shares × price
Holdings after
219k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Repeat Seller
+6score
Filing-only score

+6

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Represents shares earned upon the vesting of performance-based restricted stock units ("PRSUs") for the final performance period of the grant to the reporting person reported on January 19, 2022. The…

  2. F2

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.04 to $32.81 inclusive. The reporting person undertakes to provi…

Original filing · 0000874015-25-000078
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

IONS